Risankizumab in CD: Outcomes Remain Stable up to 3 Years Risankizumab in CD: Outcomes Remain Stable up to 3 Years
Long-term data show clinical remission and endoscopic response rates are maintained and even improve over time in patients with moderate to severe Crohn ' s disease, according to a new study.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 24, 2024 Category: Drugs & Pharmacology Tags: Gastroenterology Source Type: news
European Commission approves Pfizer & #039;s VELSIPITY ® for patients with moderately to severely Active ulcerative colitis
Pfizer Inc. (NYSE: PFE) announced that the European Commission (EC) has granted marketing authorization for VELSIPITY® (etrasimod) in the European Union to treat patients 16 years of age and older with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy, or a biological agent. (Source: World Pharma News)
Source: World Pharma News - February 23, 2024 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
Capsule Endoscopy –Guided Treatment Reduces Flares in Crohn's Capsule Endoscopy –Guided Treatment Reduces Flares in Crohn's
Patients with Crohn ' s disease who are considered high-risk as determined by capsule endoscopy but are in clinical remission benefit from a treat-to-target strategy, a new study shows.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 23, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news
A Snapshot of Ulcerative Colitis: Part III A Snapshot of Ulcerative Colitis: Part III
Advanced practice nurse Kim Kearns illustrates the importance of ulcerative colitis disease control through a hypothetical patient case. Watch to learn more!Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 20, 2024 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news
Pfizer inflammatory bowel disease drug wins EU approval
(Source: Reuters: Health)
Source: Reuters: Health - February 20, 2024 Category: Consumer Health News Source Type: news
Humans Rely on Gut Bacteria for an Enzyme that Prevents Jaundice
An absence of bilirubin-producing gut microbes may predispose individuals to some diseases, including inflammatory bowel disease. (Source: The Scientist)
Source: The Scientist - February 16, 2024 Category: Science Tags: News News & Opinion Source Type: news
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2 Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Investor Update - February 16, 2024 Category: Pharmaceuticals Source Type: news
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate small amounts of peanut, milk, egg and cashew without an allergic reaction, compared to placeboMore than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2 Detailed OUtMATCH results will be featured in a late-breaking symposiumat the 2024 AAAAI Annual MeetingBasel, 16 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food ...
Source: Roche Media News - February 16, 2024 Category: Pharmaceuticals Source Type: news
Why Bathroom Access Is a Public Health Issue
It’s not unusual to fast before a medical test to avoid skewing the results. But Dr. Zoë Gottlieb’s patients often skip meals for a different reason.
Gottlieb, a gastroenterologist and assistant professor of medicine at Mount Sinai’s Icahn School of Medicine in New York City, specializes in treating inflammatory bowel disease (IBD), an umbrella term for conditions involving chronic inflammation of the gastrointestinal tract, specifically Crohn’s disease and ulcerative colitis. People with IBD have “unreliable bowel habits,” meaning they may need to use the bathroom frequently or ...
Source: TIME: Health - February 16, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
A Snapshot of Ulcerative Colitis: Part II A Snapshot of Ulcerative Colitis: Part II
Dr Remo Panaccione presents the case of a new patient who has been suffering from ulcerative colitis for a few years. Watch to learn more about optimal treatment goals.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 13, 2024 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news
Warning signs of ulcerative colitis revealed as Louise Thompson details her hospital stint after losing 'cupfuls of blood' on holiday
Former Made in Chelsea star, Louise Thompson, rushed home from Antugua and spent two weeks in hospital being treated for a Ulcerative Colitis flare up. MailOnline reveals the warning signs. (Source: the Mail online | Health)
Source: the Mail online | Health - February 12, 2024 Category: Consumer Health News Source Type: news
What to Know About Complementary Treatments for IBD
One of the hallmarks of inflammatory bowel disease (IBD) is its unpredictability. Flares come and go, often with little rhyme or reason. Especially for people with moderate-to-severe IBD, most conventional forms of treatment—namely prescription drugs—are not enough to prevent flares or symptoms entirely.
In an effort to better control their IBD, many people with the condition turn to complementary and alternative treatments, also known as “CAM.” Definitions of CAM vary, but it usually includes herbal medicines or supplements, mind-body techniques like meditation, and Eastern medicine practi...
Source: TIME: Health - February 9, 2024 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized freelance healthscienceclimate Source Type: news
IBD is Milder, With Later Onset, in Non-US Born Patients IBD is Milder, With Later Onset, in Non-US Born Patients
Race and immigration status were both found to influence inflammatory bowel disease manifestations, which may aid in clinical management.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 7, 2024 Category: Allergy & Immunology Tags: Gastroenterology Source Type: news
Spyre Therapeutics Appoints Accomplished Biopharma and IBD Leader Mark C. McKenna, Former Chairman, President, and CEO of Prometheus Biosciences, to its Board of Directors
WALTHAM, Mass., Feb. 5, 2024 -- (Healthcare Sales & Marketing Network) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, ratio... Biopharmaceuticals, Personnel Spyre Therapeutics, Inflammatory Bowel Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 5, 2024 Category: Pharmaceuticals Source Type: news
Cell-Free DNA May Inform IBD Diagnosis Cell-Free DNA May Inform IBD Diagnosis
In patients with IBD, measurement of microbial cell-free DNA in plasma may help distinguish active from asymptomatic disease, as well as between ulcerative colitis and Crohn ' s disease.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 5, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news
